The purpose of this randomized pragmatic clinical trial is to assess the effectiveness of the association of the osteopathic manipulative treatment in individuals with chronic non-specific neck pain who receive a exercice program and pain neurocience education.
The purpose of this study is to determine whether osteopathic manipulative treatment associated exercises and pain neurocience education improves pain and function in individuals with chronic non-specific neck pain Design: a randomized single blind controlled pragmatic trial will be conducted trial. Patients (n=40) with non-specific neck pain will be randomized to receive 1) osteopathic manipulative treatment and exercise and and pain neurocience education (n=20) or 2) exercise alone and pain neurocience education (n=20). Participants will receive 8 treatments during 4 weeks. Clinical outcomes will be obtained at 1 week, four weeks and 24 weeks after end of treatment. Methods: The primary outcome will be pain measured by 11-point numerical pain rating scale. The secondary outcome will be disability measured by the Neck Disability Index, range of motion measured by Cervical Range of Motion device, Pressure pain threshold measured by electronic algometer, global perceived effect, Pain Self-Efficacy Questionnaire and pain catastrophizing scale
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
70
Exercise for stretching and strength for neck muscles and pain neuroscience education
Osteopathic manipulative treatment associated exercise for stretching and strength for neck muscles and pain neuroscience education
Sandro Groisman
Porto Alegre, Rio Grande do Sul, Brazil
Pain intensity
measured by numeric rating scale
Time frame: Measured pre and post treatment, 4 weeks after treatment and 8 weeks after treatment
Functionality and disability
measured by Neck Disability Scale
Time frame: Measured pre and post treatment, 4 weeks after treatment and 8 weeks after treatment
Range of motion
measured by CROM device
Time frame: Measured pre and post treatment, 4 weeks after treatment and 8 weeks after treatment
Pressure pain threshold
measured by electronic algometer
Time frame: Measured pre and post treatment, 4 weeks after treatment and 8 weeks after treatment
Global perceived effect
measured by global perceived rating scale
Time frame: Measured pre and post treatment, 4 weeks after treatment and 8 weeks after treatment
Self-efficacy
measured by The Pain Self-Efficacy Questionnaire
Time frame: Measured pre and post treatment, 4 weeks after treatment and 8 weeks after treatment
Catastrophizing
measure by pain catastrophizing scale
Time frame: Measured pre and post treatment, 4 weeks after treatment and 8 weeks after treatment
kinesiophobia
measure by TAMPA scale
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Measured pre and post treatment, 4 weeks after treatment and 8 weeks after treatment
McGuill
measure by Mcguill scale
Time frame: Measured pre and post treatment, 4 weeks after treatment and 8 weeks after treatment